quinazolines has been researched along with dpc 961 in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aubry, AF; Gray, V; Hobson, T; Rabel, S; Sebastian, D; Xie, M; Xu, JQ | 1 |
| Cao, K; Chen, H; Chen, S; Du, A; Espina, R; Gan, LS; Mutlib, A; Nemeth, G; Prakash, S; Shockcor, J | 1 |
| Aubry, AF; Boucher, RJ; Sebastian, DS; Williams, RC | 1 |
| Aubry, AF; Edwards, JF; Joshi, AS; Williams, RC | 1 |
| Bacheler, LT; Chidester, DR; Cocuzza, AJ; Cordova, BC; Diamond, S; Erickson-Viitanen, SK; Jeffrey, S; Klabe, RM; Ko, SS; Rodgers, JD; Weigelt, CA | 1 |
| Aungst, BJ; Bindra, DS; Nguyen, NH; Taylor, NJ | 1 |
| Confalone, PN; Davis, WP; Magnus, NA; Parsons, RL; Patel, M; Storace, L; Wood, CC | 1 |
| Caballero, J; Castro, EA; Duchowicz, PR; Fernández, FM; Fernández, M | 1 |
8 other study(ies) available for quinazolines and dpc 961
| Article | Year |
|---|---|
In-use testing of extemporaneously prepared suspensions of second generation non-nucleoside reversed transcriptase inhibitors in support of phase I clinical studies.
Topics: Anti-HIV Agents; Chromatography, High Pressure Liquid; Clinical Trials, Phase I as Topic; Pharmaceutical Preparations; Quinazolines; Quinazolinones; Quinolones; Reverse Transcriptase Inhibitors; Solubility; Spectrophotometry, Ultraviolet | 2000 |
Characterization of novel glutathione adducts of a non-nucleoside reverse transcriptase inhibitor, (S)-6-chloro-4-(cyclopropylethynyl)-4-(trifluoromethyl)-3, 4-dihydro-2(1H)-quinazolinone (DPC 961), in rats. Possible formation of an oxirene metabolic inte
Topics: Animals; Chromatography, High Pressure Liquid; Epoxy Compounds; Female; Glutathione; Magnetic Resonance Spectroscopy; Male; Mass Spectrometry; Protein Binding; Quinazolines; Quinazolinones; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Inhibitors | 2000 |
Column selection and method development for the determination of the enantiomeric purity of investigational non-nucleoside reverse transcriptase inhibitors.
Topics: Anti-HIV Agents; Chromatography, High Pressure Liquid; HIV Infections; Humans; Quinazolines; Quinazolinones; Reproducibility of Results; Reverse Transcriptase Inhibitors; Stereoisomerism | 2001 |
Chiral analysis of drug substance in clinical plasma extracts using achiral HPLC with circular dichroism detection.
Topics: Chromatography, High Pressure Liquid; Circular Dichroism; Humans; Quinazolines; Quinazolinones; Stereoisomerism; Ultraviolet Rays | 2001 |
4,1-Benzoxazepinone analogues of efavirenz (Sustiva) as HIV-1 reverse transcriptase inhibitors.
Topics: Alkynes; Animals; Benzoxazines; Cyclopropanes; HIV Reverse Transcriptase; Humans; Macaca mulatta; Oxazines; Protein Binding; Quinazolines; Quinazolinones; Reverse Transcriptase Inhibitors; Structure-Activity Relationship | 2001 |
Formulation and food effects on the oral absorption of a poorly water soluble, highly permeable antiretroviral agent.
Topics: Administration, Oral; Animals; Anti-HIV Agents; Biological Availability; Chemistry, Pharmaceutical; Dogs; Female; Food-Drug Interactions; Models, Animal; Particle Size; Quinazolines; Quinazolinones; Solubility; Tablets; Water | 2002 |
General scope of 1,4-diastereoselective additions to a 2(3H)-quinazolinone: practical preparation of HIV therapeutics.
Topics: Anti-HIV Agents; Catalysis; Combinatorial Chemistry Techniques; HIV; Humans; Molecular Structure; Quinazolines; Quinazolinones; Reverse Transcriptase Inhibitors; Spectrophotometry, Infrared; Stereoisomerism | 2003 |
QSAR for non-nucleoside inhibitors of HIV-1 reverse transcriptase.
Topics: Alkynes; Benzoxazines; Combinatorial Chemistry Techniques; Cyclopropanes; HIV Reverse Transcriptase; HIV-1; Molecular Structure; Mutation; Oxazines; Quantitative Structure-Activity Relationship; Quinazolines; Quinazolinones; Reverse Transcriptase Inhibitors | 2006 |